PubRank
Search
About
Wei-Chiang Shen
Author PubWeight™ 71.32
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Guidelines for the use and interpretation of assays for monitoring autophagy.
Autophagy
2012
20.08
2
Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.
Pharm Res
2007
2.08
3
Fusion protein linkers: property, design and functionality.
Adv Drug Deliv Rev
2012
1.67
4
Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production.
Diabetes
2013
1.44
5
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
Proc Natl Acad Sci U S A
2005
1.25
6
Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.
J Control Release
2009
1.10
7
Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers.
Pharm Res
2003
1.09
8
Arsenite-oxidizing and arsenate-reducing bacteria associated with arsenic-rich groundwater in Taiwan.
J Contam Hydrol
2010
1.09
9
Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization.
Pharm Res
2006
1.07
10
Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase.
Cancer Lett
2003
1.04
11
Oral peptide and protein delivery: unfulfilled promises?
Drug Discov Today
2003
1.04
12
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
Cancer Lett
2006
1.02
13
Insertion of the designed helical linker led to increased expression of tf-based fusion proteins.
Pharm Res
2008
1.02
14
Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells.
Biochem Pharmacol
2003
0.99
15
Reversible lipidization for the oral delivery of salmon calcitonin.
J Control Release
2003
0.97
16
Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers.
Curr Opin Mol Ther
2006
0.96
17
Blue light negatively regulates the sexual filamentation via the Cwc1 and Cwc2 proteins in Cryptococcus neoformans.
Mol Microbiol
2005
0.95
18
Reversible lipidization for the oral delivery of leu-enkephalin.
J Drug Target
2006
0.93
19
Quantitative comparison of membrane transduction and endocytosis of oligopeptides.
Biochem Biophys Res Commun
2003
0.92
20
Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway.
Biochem Pharmacol
2005
0.92
21
The transepithelial transport of a G-CSF-transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice.
Pharm Res
2004
0.92
22
Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mol Pharm
2011
0.91
23
Transferrin-oligomers as potential carriers in anticancer drug delivery.
Pharm Res
2004
0.89
24
Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins.
Mol Pharm
2011
0.89
25
Membrane transduction of oligoarginine in HeLa cells is not mediated by macropinocytosis.
Mol Pharm
2006
0.88
26
Effects of Lipofectamine 2000/siRNA complexes on autophagy in hepatoma cells.
Mol Biotechnol
2012
0.87
27
A homolog of Ste6, the a-factor transporter in Saccharomyces cerevisiae, is required for mating but not for monokaryotic fruiting in Cryptococcus neoformans.
Eukaryot Cell
2005
0.86
28
Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotide.
Pharm Res
2005
0.86
29
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.
J Control Release
2005
0.86
30
Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells.
Mol Pharm
2009
0.85
31
Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery.
J Control Release
2012
0.84
32
Evidence that membrane transduction of oligoarginine does not require vesicle formation.
Exp Cell Res
2005
0.84
33
Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells.
J Control Release
2011
0.84
34
Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells.
Int J Pharm
2008
0.83
35
Design of an in vivo cleavable disulfide linker in recombinant fusion proteins.
Biotechniques
2010
0.83
36
The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides.
J Drug Target
2010
0.83
37
Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.).
BMC Biotechnol
2012
0.82
38
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.
Adv Drug Deliv Rev
2012
0.81
39
Cryptococcus neoformans mediator protein Ssn8 negatively regulates diverse physiological processes and is required for virulence.
PLoS One
2011
0.80
40
Enhancement of insulin transport across primary rat alveolar epithelial cell monolayers by endogenous cellular factor(s).
Pharm Res
2007
0.80
41
Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery.
Proc Natl Acad Sci U S A
2012
0.80
42
Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells.
Am J Physiol Cell Physiol
2007
0.79
43
Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorption.
J Control Release
2007
0.79
44
MAP-mediated nuclear delivery of a cargo protein.
J Drug Target
2012
0.79
45
Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells.
J Control Release
2005
0.79
46
A screening for suppressor mutants reveals components involved in the blue light-inhibited sexual filamentation in Cryptococcus neoformans.
Fungal Genet Biol
2008
0.79
47
Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs.
J Control Release
2008
0.78
48
Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
Pharm Res
2003
0.78
49
Fast preparation of fungal DNA for PCR screening.
J Microbiol Methods
2011
0.78
50
Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.
Mol Pharm
2009
0.78
51
Pharmacokinetics of recombinant bifunctional fusion proteins.
Expert Opin Drug Metab Toxicol
2012
0.77
52
Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide.
J Drug Target
2012
0.77
53
Mating differentiation in Cryptococcus neoformans is negatively regulated by the Crk1 protein kinase.
Fungal Genet Biol
2010
0.77
54
Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates.
Pharm Res
2002
0.77
55
Reversible lipidization of somatostatin analogues for the liver targeting.
Eur J Pharm Biopharm
2008
0.76
56
Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers.
Eur J Pharm Biopharm
2008
0.76
57
Phylogenetic study of two truffles, Tuber formosanum and Tuber furfuraceum, identified from Taiwan.
FEMS Microbiol Lett
2009
0.76
58
Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.
Mol Pharm
2014
0.75
59
Molecular and functional expression of multidrug resistance-associated protein-1 in primary cultured rat alveolar epithelial cells.
J Pharm Sci
2008
0.75